Aromatase Inhibition And Breast Cancer (Hardbound - 2001)
In stock
SKU
9780824704124_SAP
Special Price ₹7,987.00 Regular Price ₹10,649.00
Ships in 1-2 Days!
About the Book
Presents evidence that letrozole, anastrozole, and exemestane have proven efficacy as second-line therapy and indicate increased antitumor effects and less toxicity than older aromatase inhibitors and progestins
This reference provides a state-of-the-art assessment of drugs that inhibit the synthesis of estrogens-particularly agents used to treat breast cancer-and demonstrates how the endocrinological effects of the new generation of inhibitors translate into clinical benefits.
Highlights recent key research aimed at developing novel reagents and technology to optimize drug therapies and expand their clinical applications.
With contributions from over 75 international experts, Aromatase Inhibition and Breast Cancer
reviews the preclinical development of aromatase inhibitors and their place in the current practice of breast cancer management
considers aromatase inhibitors for early stages of breast cancer as an adjuvant to surgery
explains how machine learning techniques accurately identify tumors likely to respond to treatment
gives an immunohistological evaluation of aromatase protein and RT-PCR measurements at the level of mRNA
describes how model systems based on human material have optimized the use and demonstrated the potential of aromatase inhibitors
presents the case for employing aromatase inhibitors to treat pubertal gynecomastia, prostate cancer, and benign and malignant endometrial conditions
and more
Given the remarkable endocrine effects and the clinical potential of the new generation of aromatase inhibitors, Aromatase Inhibition and Breast Cancer is an essential reference for oncologists, endocrinologists, gynecologists, obstetricians, pharmacologists, family physicians, reproductive biologists, and medical school students in these disciplines.
Presents evidence that letrozole, anastrozole, and exemestane have proven efficacy as second-line therapy and indicate increased antitumor effects and less toxicity than older aromatase inhibitors and progestins
This reference provides a state-of-the-art assessment of drugs that inhibit the synthesis of estrogens-particularly agents used to treat breast cancer-and demonstrates how the endocrinological effects of the new generation of inhibitors translate into clinical benefits.
Highlights recent key research aimed at developing novel reagents and technology to optimize drug therapies and expand their clinical applications.
With contributions from over 75 international experts, Aromatase Inhibition and Breast Cancer
Given the remarkable endocrine effects and the clinical potential of the new generation of aromatase inhibitors, Aromatase Inhibition and Breast Cancer is an essential reference for oncologists, endocrinologists, gynecologists, obstetricians, pharmacologists, family physicians, reproductive biologists, and medical school students in these disciplines.
ISBN13 | 9780824704124 |
---|---|
Product Name | Aromatase Inhibition And Breast Cancer (Hardbound - 2001) |
Price | ₹10,649.00 |
Original Price | GBP 102.00 |
Author | William R. Miller and Richard Santen |
Publisher | Marcel Dekker |
Publication Year | 2001 |
Subject | Medical, Nursing and Health Sciences |
Binding | Hardbound |
Language | English |
Pages | 322 |
Weight | 1.000000 |
Write Your Own Review
-
Icon
-
Icon
-
Icon
Lowest Price
Trusted Since 1977
-
Icon
payment method
Secure payment
Featured Books
Black Feminist Thought: Knowledge, Consciousness, and the Politics of Empowerment (Paperback - 2017)
Special Price ₹675.00 Regular Price ₹750.00
The General Theory Of Employment, Interest And Money (Paperback-2024)
Special Price ₹405.00 Regular Price ₹450.00
Amitav Ghosh’s The Shadow Lines: Critical Essays (Paperback - 2022)
Special Price ₹315.00 Regular Price ₹350.00
Login and Registration Form